Gene Therapy Strategies in Bone Tissue Engineering and Current Clinical Applications

被引:22
作者
Atasoy-Zeybek, Aysegul [1 ,2 ]
Kose, Gamze Torun [1 ,2 ]
机构
[1] Yeditepe Univ, Genet & Bioengn Dept, Fac Engn, Istanbul, Turkey
[2] METU, BIOMATEN, Ctr Excellence Biomat & Tissue Engn, Biotechnol Res Lab, Ankara, Turkey
来源
CELL BIOLOGY AND TRANSLATIONAL MEDICINE, VOL 4: STEM CELLS AND CELL BASED STRATEGIES IN REGENERATION | 2018年 / 1119卷
关键词
Bone tissue engineering; Gene activated matrices; Gene therapy; Viral vectors; MESENCHYMAL STEM-CELLS; MUSCLE-DERIVED CELLS; OSTEOGENESIS IMPERFECTA; ADENOVIRAL DELIVERY; RETROVIRAL VECTORS; ENDOGENOUS REPAIR; FEMORAL DEFECTS; IMMUNE-RESPONSE; MARROW-CELLS; TIBIAL BONE;
D O I
10.1007/5584_2018_253
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Gene therapy provides a promising approach for regeneration and repair of injured bone. Application of gene therapy has displayed increased efficiency in various animal models and preclinical trials in comparison with traditional bone grafting methods. The objective of this review is to highlight fundamental principles of gene therapy strategies in bone tissue engineering and solutions of their current limitations for the healing of bone injury. Vector types are debated for the repair of defected site due to demonstration of constraints and applications of the protocols. In recent years, the combination of gene therapy strategies and bone tissue engineering has highly gained attention. We discussed viral and non-viral mediated delivery of therapeutic protein by using scaffolds for bone tissue engineering. Although pre-clinical studies have showed that gene therapy has very promising results to heal injured bone, there are several limitations regarding with the usage of gene delivery methods into clinical applications. Choice of suitable vector, selection of transgene and gene delivery protocols are the most outstanding questions. This article also addresses current state of gene delivery strategies in bone tissue engineering for their potential applications in clinical considerations.
引用
收藏
页码:85 / 101
页数:17
相关论文
共 102 条
  • [1] Atasoy A, 2016, JSM BIOTECHNOL BIOEN, V3, P1051
  • [2] Gene therapy for bone engineering
    Balmayor, Elizabeth Rosado
    van Griensven, Martijn
    [J]. FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2015, 3
  • [3] Regional gene therapy to enhance bone repair
    Baltzer, AWA
    Lieberman, JR
    [J]. GENE THERAPY, 2004, 11 (04) : 344 - 350
  • [4] Genetic enhancement of fracture repair: healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene
    Baltzer, AWA
    Lattermann, C
    Whalen, JD
    Wooley, P
    Weiss, K
    Grimm, M
    Ghivizzani, SC
    Robbins, PD
    Evans, CH
    [J]. GENE THERAPY, 2000, 7 (09) : 734 - 739
  • [5] Gene therapy for osteoporosis: evaluation in a murine ovariectomy model
    Baltzer, AWA
    Whalen, JD
    Wooley, P
    Latterman, C
    Truchan, LM
    Robbins, PD
    Evans, CH
    [J]. GENE THERAPY, 2001, 8 (23) : 1770 - 1776
  • [6] Retroviral vectors:: new applications for an old tool
    Barquinero, J
    Eixarch, H
    Pérez-Melgosa, M
    [J]. GENE THERAPY, 2004, 11 (Suppl 1) : S3 - S9
  • [7] Delayed administration of adenoviral BMP-2 vector improves the formation of bone in osseous defects
    Betz, O. B.
    Betz, V. M.
    Nazarian, A.
    Egermann, M.
    Gerstenfeld, L. C.
    Einhorn, T. A.
    Vrahas, M. S.
    Bouxsein, M. L.
    Evans, C. H.
    [J]. GENE THERAPY, 2007, 14 (13) : 1039 - 1044
  • [8] Healing of segmental bone defects by direct percutaneous gene delivery: Effect of vector dose
    Betz, Volker M.
    Betz, Oliver B.
    Glatt, Vaida
    Gerstenfeld, Louis C.
    Einhorn, Thomas A.
    Bouxsein, Mary L.
    Vrahas, Mark S.
    Evans, Christopher H.
    [J]. HUMAN GENE THERAPY, 2007, 18 (10) : 907 - 915
  • [9] Gene transfer strategies in tissue engineering
    Bleiziffer, Oliver
    Eriksson, Elof
    Yao, Feng
    Horch, Raymund E.
    Kneser, Ulrich
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2007, 11 (02) : 206 - 223
  • [10] Adenoviral delivery of osteoprotegerin ameliorates bone resorption in a mouse ovariectomy model of osteoporosis
    Bolon, B
    Carter, C
    Daris, M
    Morony, S
    Capparelli, C
    Hsieh, A
    Mao, MF
    Kostenuik, P
    Dunstan, CR
    Lacey, DL
    Sheng, JZ
    [J]. MOLECULAR THERAPY, 2001, 3 (02) : 197 - 205